Q4 2024 Holdings
Filed 2025-02-14 | 13 holdings | $258.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moderna Inc(MRNA) | COM | 60770K107 | $96.0M | 2,308,190 | 37.2% |
| Personalis Inc(PSNL) | COM | 71535D106 | $81.2M | 14,044,943 | 31.5% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $31.1M | 772,165 | 12.0% |
| Entrada Therapeutics Inc | COM | 29384C908 | $30.1M | 1,739,768 | 11.7% |
| Alector Inc(ALEC) | COM | 014442107 | $6.7M | 3,545,719 | 2.6% |
| Sutro Biopharma Inc | COM | 869367102 | $5.0M | 2,723,509 | 1.9% |
| Absci Corporation(ABSI) | COM | 00091E109 | $2.6M | 998,163 | 1.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $1.8M | 93,414 | 0.7% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $1.4M | 1,483,758 | 0.5% |
| Lava Therapeutics NV | SHS | N51517105 | $1.1M | 1,149,345 | 0.4% |
| Carisma Therapeutics Inc(CARM) | COM | 14216R101 | $617.0K | 1,473,240 | 0.2% |
| Evaxion Biotech A/S | SPONSORED ADS | 29970R204 | $458.4K | 542,279 | 0.2% |
| Neuphoria Therapeutics Inc(NEUP) | COM | 64136E102 | $34.4K | 10,027 | 0.0% |